Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation

Shankar S. Iyer, Qiong He, John R. Janczy, Eric I. Elliott, Zhenyu Zhong, Alicia K. Olivier, Jeffrey J. Sadler, Vickie Knepper-Adrian, Renzhi Han, Liang Qiao, Stephanie C. Eisenbarth, William M. Nauseef, Suzanne L. Cassel, Fayyaz S. Sutterwala

Research output: Contribution to journalArticle

304 Citations (Scopus)

Abstract

Nlrp3 inflammasome activation occurs in response to numerous agonists but the specific mechanism by which this takes place remains unclear. All previously evaluated activators of the Nlrp3 inflammasome induce the generation of mitochondrial reactive oxygen species (ROS), suggesting a model in which ROS is a required upstream mediator of Nlrp3 inflammasome activation. Here we have identified the oxazolidinone antibiotic linezolid as a Nlrp3 agonist that activates the Nlrp3 inflammasome independently of ROS. The pathways for ROS-dependent and ROS-independent Nlrp3 activation converged upon mitochondrial dysfunction and specifically themitochondrial lipid cardiolipin. Cardiolipin bound toNlrp3 directly and interference with cardiolipin synthesis specifically inhibited Nlrp3 inflammasome activation. Together these data suggest that mitochondria play a critical role in the activation of the Nlrp3 inflammasome through the direct binding of Nlrp3 to cardiolipin.

Original languageEnglish (US)
Pages (from-to)311-323
Number of pages13
JournalImmunity
Volume39
Issue number2
DOIs
StatePublished - Aug 22 2013
Externally publishedYes

Fingerprint

Inflammasomes
Cardiolipins
Reactive Oxygen Species
Linezolid
Oxazolidinones
Mitochondria
Anti-Bacterial Agents
Lipids

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Iyer, S. S., He, Q., Janczy, J. R., Elliott, E. I., Zhong, Z., Olivier, A. K., ... Sutterwala, F. S. (2013). Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity, 39(2), 311-323. https://doi.org/10.1016/j.immuni.2013.08.001

Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. / Iyer, Shankar S.; He, Qiong; Janczy, John R.; Elliott, Eric I.; Zhong, Zhenyu; Olivier, Alicia K.; Sadler, Jeffrey J.; Knepper-Adrian, Vickie; Han, Renzhi; Qiao, Liang; Eisenbarth, Stephanie C.; Nauseef, William M.; Cassel, Suzanne L.; Sutterwala, Fayyaz S.

In: Immunity, Vol. 39, No. 2, 22.08.2013, p. 311-323.

Research output: Contribution to journalArticle

Iyer, SS, He, Q, Janczy, JR, Elliott, EI, Zhong, Z, Olivier, AK, Sadler, JJ, Knepper-Adrian, V, Han, R, Qiao, L, Eisenbarth, SC, Nauseef, WM, Cassel, SL & Sutterwala, FS 2013, 'Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation', Immunity, vol. 39, no. 2, pp. 311-323. https://doi.org/10.1016/j.immuni.2013.08.001
Iyer, Shankar S. ; He, Qiong ; Janczy, John R. ; Elliott, Eric I. ; Zhong, Zhenyu ; Olivier, Alicia K. ; Sadler, Jeffrey J. ; Knepper-Adrian, Vickie ; Han, Renzhi ; Qiao, Liang ; Eisenbarth, Stephanie C. ; Nauseef, William M. ; Cassel, Suzanne L. ; Sutterwala, Fayyaz S. / Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. In: Immunity. 2013 ; Vol. 39, No. 2. pp. 311-323.
@article{ed48873148c94daaa0430a9382b56ada,
title = "Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation",
abstract = "Nlrp3 inflammasome activation occurs in response to numerous agonists but the specific mechanism by which this takes place remains unclear. All previously evaluated activators of the Nlrp3 inflammasome induce the generation of mitochondrial reactive oxygen species (ROS), suggesting a model in which ROS is a required upstream mediator of Nlrp3 inflammasome activation. Here we have identified the oxazolidinone antibiotic linezolid as a Nlrp3 agonist that activates the Nlrp3 inflammasome independently of ROS. The pathways for ROS-dependent and ROS-independent Nlrp3 activation converged upon mitochondrial dysfunction and specifically themitochondrial lipid cardiolipin. Cardiolipin bound toNlrp3 directly and interference with cardiolipin synthesis specifically inhibited Nlrp3 inflammasome activation. Together these data suggest that mitochondria play a critical role in the activation of the Nlrp3 inflammasome through the direct binding of Nlrp3 to cardiolipin.",
author = "Iyer, {Shankar S.} and Qiong He and Janczy, {John R.} and Elliott, {Eric I.} and Zhenyu Zhong and Olivier, {Alicia K.} and Sadler, {Jeffrey J.} and Vickie Knepper-Adrian and Renzhi Han and Liang Qiao and Eisenbarth, {Stephanie C.} and Nauseef, {William M.} and Cassel, {Suzanne L.} and Sutterwala, {Fayyaz S.}",
year = "2013",
month = "8",
day = "22",
doi = "10.1016/j.immuni.2013.08.001",
language = "English (US)",
volume = "39",
pages = "311--323",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation

AU - Iyer, Shankar S.

AU - He, Qiong

AU - Janczy, John R.

AU - Elliott, Eric I.

AU - Zhong, Zhenyu

AU - Olivier, Alicia K.

AU - Sadler, Jeffrey J.

AU - Knepper-Adrian, Vickie

AU - Han, Renzhi

AU - Qiao, Liang

AU - Eisenbarth, Stephanie C.

AU - Nauseef, William M.

AU - Cassel, Suzanne L.

AU - Sutterwala, Fayyaz S.

PY - 2013/8/22

Y1 - 2013/8/22

N2 - Nlrp3 inflammasome activation occurs in response to numerous agonists but the specific mechanism by which this takes place remains unclear. All previously evaluated activators of the Nlrp3 inflammasome induce the generation of mitochondrial reactive oxygen species (ROS), suggesting a model in which ROS is a required upstream mediator of Nlrp3 inflammasome activation. Here we have identified the oxazolidinone antibiotic linezolid as a Nlrp3 agonist that activates the Nlrp3 inflammasome independently of ROS. The pathways for ROS-dependent and ROS-independent Nlrp3 activation converged upon mitochondrial dysfunction and specifically themitochondrial lipid cardiolipin. Cardiolipin bound toNlrp3 directly and interference with cardiolipin synthesis specifically inhibited Nlrp3 inflammasome activation. Together these data suggest that mitochondria play a critical role in the activation of the Nlrp3 inflammasome through the direct binding of Nlrp3 to cardiolipin.

AB - Nlrp3 inflammasome activation occurs in response to numerous agonists but the specific mechanism by which this takes place remains unclear. All previously evaluated activators of the Nlrp3 inflammasome induce the generation of mitochondrial reactive oxygen species (ROS), suggesting a model in which ROS is a required upstream mediator of Nlrp3 inflammasome activation. Here we have identified the oxazolidinone antibiotic linezolid as a Nlrp3 agonist that activates the Nlrp3 inflammasome independently of ROS. The pathways for ROS-dependent and ROS-independent Nlrp3 activation converged upon mitochondrial dysfunction and specifically themitochondrial lipid cardiolipin. Cardiolipin bound toNlrp3 directly and interference with cardiolipin synthesis specifically inhibited Nlrp3 inflammasome activation. Together these data suggest that mitochondria play a critical role in the activation of the Nlrp3 inflammasome through the direct binding of Nlrp3 to cardiolipin.

UR - http://www.scopus.com/inward/record.url?scp=84882614243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882614243&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2013.08.001

DO - 10.1016/j.immuni.2013.08.001

M3 - Article

C2 - 23954133

AN - SCOPUS:84882614243

VL - 39

SP - 311

EP - 323

JO - Immunity

JF - Immunity

SN - 1074-7613

IS - 2

ER -